Compare · DTOC vs OPCH
DTOC vs OPCH
Side-by-side comparison of Digital Transformation Opportunities Corp. (DTOC) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DTOC and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.15B, about 7.8x DTOC ($403.5M).
- OPCH has hit the wire 13 times in the past 4 weeks while DTOC has been quiet.
- OPCH has more recent analyst coverage (15 ratings vs 0 for DTOC).
- Company
- Digital Transformation Opportunities Corp.
- Option Care Health Inc.
- Price
- $27.51+123.57%
- $20.07-2.00%
- Market cap
- $403.5M
- $3.15B
- 1M return
- -
- -3.28%
- 1Y return
- -
- -36.63%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 13
- Recent ratings
- 0
- 15
Digital Transformation Opportunities Corp.
Digital Transformation Opportunities Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2020 and is based in Bellevue, Washington.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest DTOC
- Divers Stephen covered exercise/tax liability with 3,369 shares, decreasing direct ownership by 34% to 6,524 units (SEC Form 4) (Amendment)
- New insider Divers Stephen claimed ownership of 37,499 shares and claimed ownership of 63,857 units of Class B Common Stock (SEC Form 3) (Amendment)
- Divers Stephen covered exercise/tax liability with 3,369 shares, decreasing direct ownership by 34% to 6,524 units (SEC Form 4)
- Divers Stephen was granted 9,893 shares (SEC Form 4) (Amendment)
- American Oncology Network, Inc. was granted 9,893 shares (SEC Form 4)
- SEC Form 424B5 filed by Digital Transformation Opportunities Corp.
- SEC Form EFFECT filed by Digital Transformation Opportunities Corp.
- SEC Form S-8 filed by Digital Transformation Opportunities Corp.
- Digital Transformation Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form S-1/A filed by Digital Transformation Opportunities Corp. (Amendment)
Latest OPCH
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)